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ABSTRACT
Aims: To assess the effect of the Moorfields Reference
Plane on Heidelberg Retina Tomograph (HRT) rim area
repeatability and its effect on progression rates using an
event analysis.
Methods: The HRT reference plane (RP) defines
structures above as ‘‘rim’’ and below as ‘‘cup.’’ The
Moorfields RP applies the Standard RP (located 50 mm
posterior to the temporal disc margin) at baseline and
maintains the distance between the Standard RP and the
reference ring (located in the image periphery) for follow-
up images. The Moorfields RP was applied to an HRT
test–retest dataset, and rim area repeatability coefficients
were calculated. Repeatability coefficients were com-
pared between the Moorfields, Standard and 320 (located
320 mm posterior to the reference ring) RPs. The
Moorfields RP was applied to HRT images from 198 ocular
hypertensives, acquired over 6 years. HRT progression
required rim area baseline/follow-up differences exceed-
ing the repeatability coefficient in two or more sectors,
with confirmation in at least one of two consecutive
images. Field progression was assessed using Advanced
Glaucoma Intervention Study criteria.
Results: The Moorfields RP improved rim area repeat-
ability compared with the Standard RP; repeatability was
similar between the Moorfields and the 320 RP. The
frequency of identified progression using Moorfields RP
was 40% compared with 28% for the 320 RP. There was
a greater percentage with concurrent field progression
215.1% (Moorfields RP) compared with 12.1% (320 RP).
Conclusions: Although rim area repeatability was similar
using the 320 RP and the Moorfields RP, the latter
resulted in greater rates of detection of change.
Semiautomated optic nerve head (ONH) and retinal
nerve fibre layer (RNFL) imaging devices have been
commercially available for over a decade. These
devices have potential applications in the manage-
ment of patients with, or at risk of, glaucoma, both
in assisting the clinician in the discrimination of
normal optic discs from glaucomatous optic discs,1–4
and in the monitoring of progression.5–10 No con-
sensus, however, yet exists as to how best to
integrate these new technologies into clinical prac-
tice and what are the optimal operating criteria to
enable their full potential to be realised.
The Heidelberg Retina Tomograph (HRT,
Heidelberg Engineering, Heidelberg, Germany),
which works on the principle of confocal scanning
laser ophthalmoscopy, is the longest established of
the scanning imaging devices used in glaucoma
management. All new HRT software develop-
ments (the Explorer operational software is now
in its third version) enable backward compatibility,
so that images acquired using older versions of the
device, such as the original HRT (now referred to
as HRT ‘‘Classic’’), can be analysed.
One approach to monitoring progression using
the HRT is to monitor change in a particular
stereometric parameter (such as rim area; RA) over
time. A number of progression algorithms have
been described which assess RA change.5 6 9 RA has
been proposed as a good marker for progression, as
it has been shown to be a repeatable, reliable and
clinically meaningful HRT parameter.11–13
The greatest challenge in detecting progression is
the ability to discriminate true change (disease
process) from measurement variability. RA varia-
bility is strongly influenced by the position of the
reference plane (RP).11 13 14 The RP is parallel to, and
below, the retinal surface, and is used to define
structures above the plane as ‘‘rim’’ and below as
‘‘cup.’’ The default RP in the Heidelberg Explorer
software is the standard RP (SRP), located 50 mm
posterior to the temporal disc margin. An alter-
native RP, the 320 RP is located 320 mm posterior
to the reference ring (which is located in the image
periphery) and has been shown to result in less RA
variability.12 On this basis, our group has pre-
viously proposed the use of the 320 RP with RA-
based progression algorithms.6 9
We have recently described and tested a novel
RP, the Moorfields RP (MRP).15 The MRP applies
the Standard RP in the baseline image and then
keeps the height difference between the baseline
RP and the reference ring constant for follow-up
images (fig 1).
The aim of this study was to further investigate
the performance of the MRP. First, the effect of the
MRP on RA repeatability was assessed. Second, its
effect on the detection of glaucoma progression
was investigated by applying the MRP to an HRT
RA event analysis (EA) algorithm.
MATERIALS AND METHODS
Assessment of rim area repeatability
Repeatability was assessed by applying the MRP to
HRT images acquired as part of an HRT test–retest
study which has been described in detail else-
where.11 12 In summary, 43 eyes with ocular
hypertension (OHT) and 31 with primary open-
angle glaucoma (POAG) were imaged by two
experienced observers using the HRT Classic on
the same date, and on a second date within
6 weeks of the date of the first image acquisition.
Subjects had no previous history of intraocular
surgery and had prior experience of ONH imaging
using the HRT. The acquired HRT Classic single
topographies were imported as HRTport files into
a beta version of HRT Explorer Version 3.1.2.0,
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incorporating the MRP, with which mean topography images
were generated.
The British Standards Institution definition of measurement
error, the repeatability coefficient (RC), was used to quantify
RA repeatability.16 Ninety-five per cent of intertest differences
are expected to lie within the value of the RC. RC was
calculated as:
Interobserver/intervisit RA RCs (using the MRP) were
calculated for the six predefined HRT sectors, namely super-
otemporal (ST), inferotemporal (IT), temporal (T), superonasal
(SN), inferonasal (IN) and nasal (N). HRT image quality was
defined according to the mean pixel height standard deviation
(MPHSD). Each subject eye was ranked by MPHSD (taken as
the mean MPHSD of observation 1 and observation 2) with
good-quality images ranked in the upper tertile, medium-quality
images in the middle tertile and poor-quality images in the
lower tertile. Sector RA RCs generated using the MRP were
compared against previously published RCs generated using the
SRP and 320 RP.6 12
Assessment of HRT progression
The interobserver/intervisit RA RCs generated using the MRP
were used as the basis for ‘‘criteria for change’’ in an HRT event
analysis progression algorithm.6 In the current study, HRT
progression was flagged if a decrease in sector RA (baseline–
follow-up) exceeded the sector RA RC for that level of image
quality (taken as the mean of the baseline and follow-up
MPHSD) in two or more sectors and confirmed in at least two
out of three consecutive images. Significant improvement was
defined using the same criteria, except requiring an increase in
sector RA from baseline to follow-up. This strategy was
classified as event analysis 2 (EA2) in our previous report.6
The EA2 strategy was applied to HRT mean topographies
acquired using HRT ‘‘Classic,’’ from 198 OHT subjects and 21
control subjects followed prospectively with regular HRT and
VF testing (1994 to 2001), originally recruited to a betaxolol
versus placebo study.17 In brief, OHT was defined as an IOP
.22 mm Hg and ,35 mm Hg on two or more occasions within
a 2-week period and a baseline mean Advanced Glaucoma
Intervention Study (AGIS) VF score of 0 (Humphrey Field
Analyzer, full-threshold 24–2 program).18 Control subjects were
recruited from senior citizens groups or were the spouses or
friends of subjects in the OHT cohort; they were not attending
the eye clinic as patients and were not seeking care or
undergoing check-ups.8 Controls had a baseline IOP of less
than 21 mm Hg and normal baseline VF test results (same
criteria as in the OHT group), and were excluded if there was a
self-reported family history of glaucoma or any coexistent
ocular or neurological pathology. There was no significant age
difference between the OHT and control groups (p=0.09,
Student t test), and both groups had similar ethnic back-
grounds, both being predominantly (.95%) of European
descent. In the current study, the same eye was selected for
analysis as had been randomised in the original study. The OHT
eye randomisation was based on risk to glaucomatous conver-
sion, classified according to pattern electroretinogram results,
IOP and cup-to-disc area ratio at the time of recruitment;17
control eyes were selected by simple randomisation.
HRT mean topographies were generated and analysed using a
beta version of Heidelberg Explorer Version 3.1.2.0 (Heidelberg
Engineering, Heidelberg, Germany). The MRP was used for all
analyses. A single observer (NGS) drew contour lines onto the
baseline mean topographies. Contour lines were exported
automatically to follow-up images. Manual alignment was used
to correct for automatically ‘‘misplaced’’ contour lines or if
there was a magnification change. Each subject had a minimum
of five HRT mean topographies, with all image qualities
included except where satisfactory contour line alignment
could not be achieved. In total, eight mean topographies were
excluded from the study, either as a result of ‘‘double imaging’’
or if the image was so grainy as to prevent adequate
visualisation of Elschnig’s ring. The baseline HRT image was
the first mean topography available for each subject, and the
baseline VF was taken as the VF test coinciding with, or nearest
in acquisition date to, the baseline HRT mean topography.
In the absence of an accepted gold standard for defining
glaucomatous progression, two proxy measures were used to
generate an estimated ‘‘specificity’’ for EA2 using the MRP. The
first proxy measure was the number of control subjects (of 21)
progressing, and the second was the number of subjects (of 219)
demonstrating significant improvement using the applied
‘‘change’’ criteria. The number of OHT subjects identified as
progressing (‘‘positive hit rate’’) was comparedwith the previously
published results for the 320 RP applied to the same OHT cohort.6
HRT progression was compared with VF progression, which was
identified if the AGIS VF score increased from 0 to 1 or more and
was reproducible in three consecutive VF tests in the same region
of the VF.18 Previous studies have estimated the specificity of the
AGIS VF strategy at 91–100%.19–21
The study adhered to the tenets of the Declaration of
Helsinki and had local ethical committee approval, in addition
to subjects’ informed consent. All statistical analyses were
performed using Medcalc Version 7.4.2.0 (Medcalc Software,
Mariakerke, Belgium).
RESULTS
Interobserver/intervisit RA RCs for the SRP, 320 RP and MRP
are shown in table 1.
Regardless of image quality, RA repeatability was generally
poorer (higher RC values) for the SRP than with the 320 RP and
MRP. Differences were equivocal between RA repeatability
using the 320 RP and the MRP, except in the temporal sector of
Figure 1 Location of the Moorfields reference plane. The height of the
reference plane in the baseline image is the same as for the standard
reference plane, located 50 mm posterior to the temporal disc margin
(white disc with black outline). The height difference between the
baseline reference plane and the reference ring (black circle with grey
outline) is kept constant for follow-up images. Figure previously
published in Strouthidis NG, Gardiner SK, Sinapis C, et al. The spatial
pattern of rim loss in ocular hypertension. Invest Ophthalmol Vis Sci
2009;50:3737–42.  Association for Research in Vision and
Ophthalmology.
Clinical science
Br J Ophthalmol 2009;93:1510–1513. doi:10.1136/bjo.2008.148031 1511
group.bmj.com on March 17, 2011 - Published by bjo.bmj.comDownloaded from 
medium- and poor-quality images where the MRP generated RCs
of considerably greater magnitude than the 320 RP. A formal
comparison of the intertest RA differences used to generate the
RCs was performed using the generalised estimating equation
technique.22 This method is related to the standard least-squares
linear regression but adjusts for the fact that the RA intertest
differences from the six sectors are correlated, as they are derived
from the same subject (in each of the 74 data sets). Using the
MRP, the mean intertest RA difference was 0.001 mm2 greater
than with the 320 RP, although this did not reach statistical
significance (p=0.229). Using the SRP, the mean intertest RA
difference was 0.004 mm2 greater than with the 320 RP (p=0.04)
and 0.003 mm2 greater than with the MRP (p=0.037).
The baseline demographics and characteristics of subjects
included in the progression analysis are summarised in table 2.
The specificity for the EA2 strategy following application of
the MRP was estimated as follows:
1. Number of subjects (OHT and control) improving=15
(out of 219). Estimated specificity= (204/219)6100=93.2%
(95% confidence interval 88.7 to 95.9%).
2. Number of controls progressing=2 (out of 21). Estimated
specificity= (19/21)6100=90.5% (95% confidence interval
68.2 to 98.3%).
Application of the MRP to the EA2 strategy resulted in an
increased number of OHT subjects identified as progressing by
HRT compared with the previously published results for the
320 RP, 24.8% of OHT subjects compared with 16.2%
(p=0.046, Fisher exact test).6 The agreement between progres-
sion identified by EA2 using either the MRP or the 320 RP and
progression identified by AGIS criteria is illustrated in a Venn
diagram (fig 2). Of the 43 subjects who progressed according to
the AGIS criteria, 70% also progressed by RA using the MRP,
compared with 56% who progressed using the 320RP. This
difference was not significant (p=0.265, Fisher exact test).
DISCUSSION
The MRP was designed with the intention of combining
positive attributes of both the SRP and the 320 RP, while at the
same time compensating for their respective shortcomings. The
320 RP is anchored to a reference ring located in the image
periphery. As such, the height of the reference surface (the
retina in the image periphery) is likely to be more stable than
the reference surface for the SRP. The SRP is anchored at the
temporal disc margin, a location which may shift posteriorly as
glaucoma progresses and is subject to artefact in the surface
height determination near the Elschnig ring. The SRP does,
however, have an advantage over the 320 RP in that it can
accommodate the large degree of morphological variation of the
ONH, such as oblique insertion. The 320 RP, by contrast, will
be prone to generating inaccurate stereometric parameter
measurements when applied to such ONHs.
The results of this study indicate that the 320 RP and MRP
generate more repeatable RA measurements than the SRP,
regardless of image quality. The differences in RA repeatability
between the MRP and the 320 RP are equivocal. Our results
Table 1 Interobserver/intervisit rim area repeatability coefficients (mm2) for the standard reference plane,
320 reference plane and Moorfields reference plane
T N ST IT SN IN
Good image quality (MPHSD ,21)
Standard reference plane 0.043 0.033 0.011 0.018 0.017 0.007
320 reference plane 0.050 0.014 0.012 0.026 0.008 0.007
Moorfields reference plane 0.031 0.023 0.013 0.012 0.009 0.012
Medium image quality (MPHSD 21–35)
Standard reference plane 0.083 0.047 0.036 0.047 0.018 0.032
320 reference plane 0.058 0.031 0.026 0.026 0.022 0.015
Moorfields reference plane 0.082 0.024 0.031 0.025 0.016 0.015
Poor image quality (MPHSD .35)
Standard reference plane 0.134 0.092 0.066 0.065 0.052 0.032
320 reference plane 0.109 0.068 0.057 0.046 0.049 0.029
Moorfields reference plane 0.161 0.071 0.055 0.049 0.042 0.024
IN, inferonasal Heidelberg Retina Tomograph sector; IT, inferotemporal Heidelberg Retina Tomograph sector; MPHSD, mean pixel
height standard deviation; N, nasal Heidelberg Retina Tomograph sector; SN, superonasal Heidelberg Retina Tomograph sector; ST,
superotemporal Heidelberg Retina Tomograph sector; T, temporal Heidelberg Retina Tomograph sector.
Table 2 Baseline demographics and characteristics of subjects
included in the progression analysis
Ocular hypertension Control
No of subjects 198 21
Age (years) 60 (32 to 79) 65 (41 to 77)
Length of follow-up (years) 6.0 (2.3 to 7.2) 5.3 (3.1 to 6.8)
No of Heidelberg Retina Tomograph
examinations
10 (5 to 16) 9 (8 to 11)
No of visual-field examinations 17 (5 to 33) 9 (7 to 14)
Baseline mean defect (dB) +0.1 (+3.0 to 22.7) +0.1 (+2.6 to 22.4)
Baseline global rim area (mm2) 1.24 (0.63 to 2.31) 1.35 (0.86 to 2.51)
Image quality throughout study (mean
pixel height SD)
20 (7 to 186) 23 (9 to 80)
Values are given as the median (range).
Figure 2 Venn diagram depicting the percentage of ocular hypertensive
subjects (of 198) progressing by Heidelberg Retina Tomograph (HRT)
Event Analysis 2 (EA2) and by AGIS visual-field (VF) criteria. Values in
bold are for the Moorfields Reference Plane, and values in italics are for
the 320 reference plane.6 The estimated specificity for the HRT criteria is
approximately 93%.
Clinical science
1512 Br J Ophthalmol 2009;93:1510–1513. doi:10.1136/bjo.2008.148031
group.bmj.com on March 17, 2011 - Published by bjo.bmj.comDownloaded from 
suggest that the SRP has a greater tendency to generate ‘‘noisy’’
RA measurements and should therefore not be considered for
use when using RA to monitor progression. This does not,
however, preclude the application of the SRP for other purposes;
it is important to note that the Moorfields Regression Analysis
algorithm uses RA measurements generated using the SRP.2
Alternative progression algorithms, which are stereometric-
parameter-independent have been proposed. One such algorithm
is topographical change analysis (TCA), which is incorporated
into the current Explorer software.23 Our group has also described
amethod, statistic imagemapping (SIM), which has been adapted
from neuroimaging techniques.24 Both TCA and SIM measure
progression by monitoring the pixel-based height change. Unlike
RA, the anatomical correlates of SIM and TCA are less easily
understood. HRT RA change has a direct anatomical corollorary,
which is well understood and may be observed both by clinical
examination and by assessment of optic disc stereo-photographs.
It is possible that surface height changes within the disc margin,
identified by either TCA or SIM, may reflect deformation at the
level of the lamina cribrosa, but this has yet to be proven.25 TCA
has been shown to have poor agreement as regards progression
with disc stereo-photographs,26 whereas RA-based techniques
have a slightly better agreement with disc photography.27 It
should be stressed that stereo-photography is not an absolute gold
standard for glaucomatous progression; therefore, subjects
identified as progressing by TCA or SIM but not by photographic
examination may very well still be progressing, but in a fashion
which cannot be appreciated using the latter technique. As most
of our understanding regarding progressive structural changes in
glaucoma has been based on careful clinical observations, we
would encourage the continued use of stereometric parameter-
based (particularly RA) progression algorithms in practice. This
recommendation is not exclusive, however, as SIM and TCA are
likely to pick up a proportion of genuine progressors which are
different from those identified by RA change.
The MRP identified more OHT subjects as progressing than
the 320 RP, with a similar estimated specificity. The MRP
showed improved agreement with VF progression, although this
was not statistically significant. The estimated specificity range
for EA2 using the 320 RP (94.1–95.2%) is slightly higher than
that generated for EA2 using the MRP (90.5–93.2%); given the
number of subjects included in these estimates, it is likely that
there is no real difference in specificity; however, small changes
in specificity can have a large effect on the ‘‘positive hit rate.’’
Given the similar values obtained for our two different
approaches to obtain proxy measures of specificity, it is
reasonable to postulate that the specificity of the criteria
applied to the MRP- and the 320 RP-generated RA are very
similar. The comparison between progression rates using the
different RPs is therefore fair, and the observed differences in
‘‘positive hit rate’’ are not simply the result of different
specificity values. These results suggest that, at a similar level
of specificity, the MRP will identify more subjects as progres-
sing than with the 320 RP and that these subjects are more
likely to be genuine progressors. In our previous report we
highlighted the higher ‘‘signal to noise’’ ratio of the MRP, and
this most probably accounts for the improved detection of
progression over the 320 RP, rather than RA repeatability which
is similar between the two planes. Although these results
require confirmation based on further prospective longitudinal
studies, the apparent improved performance of the MRP over
the 320 RP in detecting RA progression supports its clinical
application in the longitudinal detection of structural change
using HRT stereometric parameters.
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